Non-biopsy methods to determine hepatic fibrosis.

about

Non-biopsy methods to determine hepatic fibrosis.

Item

http://www.wikidata.org/entity/Q42160967

description

2009 nî lūn-bûn

@nan

2009年の論文

@ja

2009年論文

@yue

2009年論文

@zh-hant

2009年論文

@zh-hk

2009年論文

@zh-mo

2009年論文

@zh-tw

2009年论文

@wuu

2009年论文

@zh

2009年论文

@zh-cn

name

Non-biopsy methods to determine hepatic fibrosis.

@en

Non-biopsy methods to determine hepatic fibrosis.

@nl

type

Item

label

Non-biopsy methods to determine hepatic fibrosis.

@en

Non-biopsy methods to determine hepatic fibrosis.

@nl

prefLabel

Non-biopsy methods to determine hepatic fibrosis.

@en

Non-biopsy methods to determine hepatic fibrosis.

@nl

P1476

Non-biopsy methods to determine hepatic fibrosis

@en

P2093

Carmen Fierbinteanu-Braticevici

http://www.w3.org/2001/XMLSchema#string

Monica Purcarea

http://www.w3.org/2001/XMLSchema#string

P2860

Overview of the diagnostic value of biochemical markers of liver fibrosis (FibroTest, HCV FibroSure) and necrosis (ActiTest) in patients with chronic hepatitis C

Noninvasive markers of fibrosis in nonalcoholic fatty liver disease: Validating the European Liver Fibrosis Panel and exploring simple markers

Hepatic stellate cells: protean, multifunctional, and enigmatic cells of the liver

Hepatic vein transit times using a microbubble agent can predict disease severity non-invasively in patients with hepatitis C

Prediction of liver fibrosis and cirrhosis in chronic hepatitis B infection by serum proteomic fingerprinting: a pilot study.

Diagnostic value of serum protein profiling by SELDI-TOF ProteinChip compared with a biochemical marker, FibroTest, for the diagnosis of advanced fibrosis in patients with chronic hepatitis C.

Sampling error and intraobserver variation in liver biopsy in patients with chronic HCV infection.

Prospective comparison of transient elastography, Fibrotest, APRI, and liver biopsy for the assessment of fibrosis in chronic hepatitis C.

Identification of two gene variants associated with risk of advanced fibrosis in patients with chronic hepatitis C.

FibroTest and FibroScan for the prediction of hepatitis C-related fibrosis: a systematic review of diagnostic test accuracy.

P304

401-406

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P577

2009-10-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

20108754

http://www.w3.org/2001/XMLSchema#string

P932

3019013

http://www.w3.org/2001/XMLSchema#string